NCT01553474

Brief Summary

Background: \- The Age-Related Eye Disease Study 2 (AREDS 2) is looking at different eye diseases. Study participants will provide blood and saliva samples. The samples will be stored for research on eye diseases. Objectives: \- To collect blood and saliva samples for AREDS 2 research. Eligibility: \- AREDS 2 research study participants. Design:

  • Participants will provide blood and saliva samples.
  • The samples will be submitted with personal and medical information. This information will be collected during the AREDS 2 procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2012

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

March 13, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 14, 2012

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2013

Completed
Last Updated

July 29, 2019

Status Verified

February 5, 2013

First QC Date

March 13, 2012

Last Update Submit

July 26, 2019

Conditions

Keywords

Age-Related Macular Degeneration (AMD)Eye Diseases

Eligibility Criteria

Age55 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be eligible if they were enrolled in the AREDS2 protocol and willing to have their blood drawn and saliva collected.

You may not qualify if:

  • Participants will not be eligible if they were not enrolled in AREDS2 and are not willing to have their blood drawn and saliva collected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

MeSH Terms

Conditions

Macular DegenerationEye Diseases

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal Diseases

Study Officials

  • Wai T Wong, M.D.

    National Eye Institute (NEI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
NIH

Study Record Dates

First Submitted

March 13, 2012

First Posted

March 14, 2012

Study Start

February 24, 2012

Study Completion

February 5, 2013

Last Updated

July 29, 2019

Record last verified: 2013-02-05

Locations